Stocks & Investing
Stocks and Investing
Stocks and Investing
Tue, January 12, 2021
[ Tue, Jan 12th 2021
] - WOPRAI
[ Tue, Jan 12th 2021
] - WOPRAI
[ Tue, Jan 12th 2021
] - WOPRAI
[ Tue, Jan 12th 2021
] - WOPRAI
[ Tue, Jan 12th 2021
] - WOPRAI
[ Tue, Jan 12th 2021
] - WOPRAI
Mon, January 11, 2021
[ Mon, Jan 11th 2021
] - WOPRAI
[ Mon, Jan 11th 2021
] - WOPRAI
[ Mon, Jan 11th 2021
] - WOPRAI
[ Mon, Jan 11th 2021
] - WOPRAI
[ Mon, Jan 11th 2021
] - WOPRAI
[ Mon, Jan 11th 2021
] - WOPRAI
[ Mon, Jan 11th 2021
] - WOPRAI
[ Mon, Jan 11th 2021
] - WOPRAI
[ Mon, Jan 11th 2021
] - WOPRAI
[ Mon, Jan 11th 2021
] - WOPRAI
[ Mon, Jan 11th 2021
] - WOPRAI
[ Mon, Jan 11th 2021
] - WOPRAI
[ Mon, Jan 11th 2021
] - WOPRAI
[ Mon, Jan 11th 2021
] - WOPRAI
[ Mon, Jan 11th 2021
] - WOPRAI
[ Mon, Jan 11th 2021
] - WOPRAI
[ Mon, Jan 11th 2021
] - WOPRAI
[ Mon, Jan 11th 2021
] - WOPRAI
Alexander Nowak Initiated (VVOS) at Strong Buy and Held Target at $300 on, Jan 11th, 2021
Alexander Nowak of Craig-Hallum, Initiated "Vivos Therapeutics, Inc." (VVOS) at Strong Buy and Held Target at $300 on, Jan 11th, 2021.
Alexander has made no other calls on VVOS in the last 4 months.
There is 1 other peer that has a rating on VVOS. Out of the 1 peers that are also analyzing VVOS, 0 agree with Alexander's Rating of Hold.
This is the rating of the analyst that currently disagrees with Alexander
- Scott Henry of "Roth Capital" Initiated at Strong Buy and Held Target at $300 on, Tuesday, January 5th, 2021
